Market Movers (8-K)
See all →NYSE
MAC
Macerich COThe Macerich Partnership, L.P. has successfully issued $775 million in 2.25% Exchangeable Senior Notes due 2031, with The Macerich Company providing a full guarantee.
Capital raise
NYSE
MAC
Macerich COThe Macerich Company has filed a new automatic shelf registration statement and prospectus supplements to continue its at-the-market offering program and facilitate potential future stock issuances.
Capital raise
NYSE
MAC
Macerich COThe Macerich Company has successfully closed an offering of 14,000,000 shares of common stock and subsequently exercised its option to purchase an additional 2,100,000 shares, with proceeds intended for acquisitions and general corporate purposes.
Capital raise
NYSE
MAC
Macerich COThe Macerich Company has entered into an underwriting agreement for the offer and sale of 14,000,000 shares of common stock.
Capital raise
NYSE
MAC
Macerich COThe Macerich Company's annual meeting saw the election of eight directors, approval of executive compensation, and ratification of KPMG LLP as its auditor for fiscal year 2026.
NYSE
MAC
Macerich COThe Macerich Company presented an investor presentation on June 1, 2026, detailing its 'Path Forward Plan v 3.0,' emphasizing a strategic shift towards high-quality Class A malls and significant progress in operational improvements and leverage reduction.
Quarterly Earnings (10-Q)
See all →NYSE
MAC
Macerich COThe Macerich Company's Q2 2026 10-Q filing reveals ongoing net losses and strategic portfolio adjustments, including acquisitions and debt management, with a focus on deleveraging.
Worse than expected
Capital raise
NYSE
MAC
Macerich COThe Macerich Company's Q1 2026 Form 10-Q filing details a net loss of $36.35 million, a decrease from the prior year, alongside strategic portfolio adjustments and a strengthened credit facility.
Capital raise
Worse than expected
NYSE
MAC
Macerich COMacerich reports improved Q3 2025 net loss and increased FFO, driven by active portfolio management and leasing gains, despite higher interest expenses and ongoing debt challenges.
Delay expected
Capital raise
NYSE
MAC
Macerich COMacerich reports a net loss in Q2 2025 despite strong leasing spreads and revenue growth, driven by strategic portfolio adjustments and increased interest expenses.
Capital raise
Worse than expected
NYSE
MAC
Macerich COMacerich's Q1 2025 shows increased leasing revenue and a reduced net loss, driven by strategic acquisitions and dispositions, as the company progresses with its 'Path Forward Plan'.
Worse than expected
Capital raise
NYSE
MAC
Macerich COMacerich's Q3 2024 results show a net loss, impacted by asset write-downs and joint venture losses, but also include gains from strategic dispositions and increased leasing revenue.
Worse than expected
Capital raise
Annual Reports (10-K)
NYSE
MAC
Macerich COMacerich reports a net loss in 2025 but shows FFO growth and positive leasing trends amid strategic portfolio adjustments and ongoing debt management efforts.
Capital raise
Delay expected
NYSE
MAC
Macerich COMacerich's 2024 10-K filing highlights strategic acquisitions, dispositions, and financing activities aimed at deleveraging and strengthening its core retail assets.
Capital raise
Worse than expected
NYSE
MAC
Macerich COMacerich's 10-K filing describes the terms and provisions of its common stock registered under the Securities Exchange Act of 1934, including voting, dividend, and liquidation rights, as well as restrictions on transfer and ownership to maintain REIT status.
Insider Trading (Form 4)
See all →NYSE
MAC
Macerich COMacerich Co. Director Andrea M. Stephen reported a transaction involving phantom stock units, convertible on a 1-for-1 basis to common stock.
NYSE
MAC
Macerich COEnrique Hernandez Jr., a Director at Macerich Co., reported the acquisition of phantom stock units and an increase in beneficial ownership of common stock.
NYSE
MAC
Macerich COEnrique Hernandez Jr., a Director at The Macerich Company, received an award of 6,720 restricted stock units under the company's equity incentive plan.
NYSE
MAC
Macerich COMacerich Director Andrea M. Stephen was granted restricted stock units under the company's equity incentive plan.
NYSE
MAC
Macerich COMacerich Co. director Diana Laing was awarded restricted stock units under the company's equity incentive plan.
NYSE
MAC
Macerich CODirector Marianne Lowenthal was awarded 6,720 restricted stock units by The Macerich Company as non-cash compensation.
Proxy Statements (Def-14A)
NYSE
MAC
Macerich COThe Macerich Company announces its 2026 Annual Meeting of Stockholders, to be held virtually on June 1, 2026, with key proposals including director elections and executive compensation.
NYSE
MAC
Macerich COMacerich Company announces its 2025 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation, and auditor ratification.
NYSE
MAC
Macerich COMacerich Company announces its 2025 Annual Meeting of Stockholders to be held virtually on June 2, 2025, featuring proposals for director elections, executive compensation approval, and auditor ratification.
NYSE
MAC
Macerich COMacerich Company has filed a definitive proxy statement with the SEC, indicating upcoming shareholder actions.
NYSE
MAC
Macerich COMacerich is asking stockholders to approve an amendment to its Employee Stock Purchase Plan to increase the share reserve by 500,000 shares.
Schedule 13G - Passive Investments
See all →NYSE
MAC
Macerich COSCHEDULE: State Street Discloses Macerich Stake
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.5% of Macerich Co. common stock as of June 30, 2026.
NYSE
MAC
Macerich COFMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 10.2% of Macerich Co.'s common stock as of April 30, 2026.
NYSE
MAC
Macerich COFMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 9.3% of Macerich Co.'s common stock as of March 31, 2026.
NYSE
MAC
Macerich COVanguard Capital Management has reported beneficial ownership of 13,593,968 shares, representing 5.29% of Macerich Co.'s common stock, as of March 31, 2026.
NYSE
MAC
Macerich COVanguard Portfolio Management has reported a beneficial ownership of 9.99% in Macerich Co. (MAC) as of March 31, 2026, holding over 25.6 million shares.
NYSE
MAC
Macerich COSmead Capital Management, Inc., along with William W. Smead and Cole W. Smead, has filed a Schedule 13G, reporting beneficial ownership of 12,155,332.57 shares of Macerich Co. common stock, representing 4.74% of the class.